Androgen insensitivity syndrome medical therapy: Difference between revisions
| Line 8: | Line 8: | ||
==Medical Therapy== | ==Medical Therapy== | ||
===General management=== | |||
*Management of androgen insensitivity syndrome should address: <ref name="pmid22698698">{{cite journal| author=Hughes IA, Davies JD, Bunch TI, Pasterski V, Mastroyannopoulou K, MacDougall J| title=Androgen insensitivity syndrome. | journal=Lancet | year= 2012 | volume= 380 | issue= 9851 | pages= 1419-28 | pmid=22698698 | doi=10.1016/S0140-6736(12)60071-3 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22698698 }} </ref> | |||
**Functional | |||
**Sexual | |||
**Psychological issues such as disclosure | |||
**Gonadectomy and subsequent hormone replacement | |||
**Creation of a functional vagina, and provision of genetic advice. | |||
**Care needs to be individualised, flexible, and holistic. | |||
**Management is dependent wholly on a multidisciplinary team. | |||
==References== | ==References== | ||
Revision as of 00:31, 7 July 2017
|
Androgen insensitivity syndrome Microchapters |
|
Differentiating Androgen insensitivity syndrome from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Androgen insensitivity syndrome medical therapy On the Web |
|
American Roentgen Ray Society Images of Androgen insensitivity syndrome medical therapy |
|
Directions to Hospitals Treating Androgen insensitivity syndrome |
|
Risk calculators and risk factors for Androgen insensitivity syndrome medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aravind Reddy Kothagadi M.B.B.S[2]
Overview
A multidisciplinary approach is recommended for clinical management from infancy through to adulthood. Hormone replacement therapy is needed following gonadectomy. Patients who choose to retain the gonads are at risk of developing germ cell tumors for which sensitive circulating tumor markers may soon become available. [1]
Medical Therapy
General management
- Management of androgen insensitivity syndrome should address: [2]
- Functional
- Sexual
- Psychological issues such as disclosure
- Gonadectomy and subsequent hormone replacement
- Creation of a functional vagina, and provision of genetic advice.
- Care needs to be individualised, flexible, and holistic.
- Management is dependent wholly on a multidisciplinary team.
References
- ↑ Mongan NP, Tadokoro-Cuccaro R, Bunch T, Hughes IA (2015). "Androgen insensitivity syndrome". Best Pract Res Clin Endocrinol Metab. 29 (4): 569–80. doi:10.1016/j.beem.2015.04.005. PMID 26303084.
- ↑ Hughes IA, Davies JD, Bunch TI, Pasterski V, Mastroyannopoulou K, MacDougall J (2012). "Androgen insensitivity syndrome". Lancet. 380 (9851): 1419–28. doi:10.1016/S0140-6736(12)60071-3. PMID 22698698.